Survival in most affluent

Slides:

Advertisements

Similar presentations

Age-Standardised One-, Five- and Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Five- and ten-year survival.

Advertisements

Sinus Cancer (C30, C31): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Ad Hoc Sex Survival (%)

Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

The Five Most Common Cancers:

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Bladder Cancer (C67): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 66.5% 63.6% patients treated for cancer.

Hypopharyngeal Cancer (C12, C13):

Colon Cancer (C18): Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed and predicted.

Hodgkin Lymphoma Subtypes:

Salivary Gland Cancer (C07, C08):

The Five Most Commonly Diagnosed Cancers in Females

Kidney Cancer (C64-C66, C68): Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries Data consists of both observed.

The Five Most Common Cancers:

Age-Standardised Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Breast is for female only. Laryngeal is for.

Breast Cancer (C50): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 87.5% 83.3% 87.4% patients treated for cancer.

Hodgkin Lymphoma (C81): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 34.2% 43.8% 39.2% patients treated for.

The 5 Most Commonly Diagnosed Cancers in Males

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Thyroid Cancer (C73): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Males, England and Wales, Ten-year survival for is predicted.

Gallbladder Cancer (C23-C24):

Anal Cancer (C21): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, Ten-year survival for is predicted.

Non-Melanoma Skin Cancer (C44): 2014

Hodgkin Lymphoma Subtypes:

The 20 Most Common Cancers in 2012

Oral Cavity Cancer (C03, C04, C05, C06):

Brain, Other CNS and Intracranial Tumours, Malignant (C70-C72, C75

One-, Five- and Ten-Year Net Survival (%), Men, Aged 15-90, England

Stomach Cancer (C16): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 39.0% 51.7% 48.0% patients treated for cancer.

Kidney Cancer (C64-C66,C68): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England.

Non-Hodgkin Lymphoma (C82-C85): 2014

The 10 Most Common Cancers: 2012

The 5 Most Commonly Diagnosed Cancers in Males

The 10 Most Common Cancers in 2011

The 10 Most Common Cancers: 2012

Malignant Brain, Other CNS and Intracranial Tumours (C70-C72, C75

The 10 Most Common Cancers: 2013

Malignant Melanoma (C43): 2014

Statistically Significant Cancers, Females, England,

Kidney Cancer (C64-C66,C68): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.5% 62.2% 59.2% patients treated.

All Teenager's and Young Adult's Cancers:

Hodgkin Lymphoma (C81): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Benign Brain, Other CNS and Intracranial Tumours (D32-D33, D35. 2-D35

Statistically Significant Cancers, Males, England,

Non-Hodgkin Lymphoma (C82-C86): 2014

Myeloma (C90): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Soft Tissue Sarcoma: Relative Survival (%), Adults Aged , UK 1-Year

All Children’s Cancers:

Tongue Cancer (C01, C02 excluding C02.4):

Lung Cancer (C33-C34): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 50.3% 51.4% 50.9% patients treated for.

Acute Myeloid Leukaemia (C92. 0, C92. 4, C92. 5, C92. 6, C92. 8, C93

Myeloma (C90): 2014 Cancer Patient Experience Survey, by Sex, England

Stomach cancer Scotland, Patients diagnosed

Age-Standardised One-, Five- and Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Five- and ten-year survival.

Leukaemia (C91-C95): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Oropharyngeal Cancer (C09, C10, C02.4):

The 10 Most Common Cancers in 2011

Cancer Patient Experience Survey, by Sex, England Female Male Persons

The 20 Most Common Causes of Cancer Death: and

The 10 Most Common Cancers: 2013

The Three Most Common Cancers: 2013

The Four Most Common Causes of Death by Age,

Penile Cancer (C60): One-, Five- and Ten-Year Net Survival (%), Men, Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%) Survival.

Haematological Cancers:

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Bone Sarcoma (C40-C41): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-90, England 1-Year 5-Year 10-Year Survival (%) Survival (%)

The 20 Most Common Cancers in 2013

Presentation transcript:

Survival in most affluent Selected Common Cancers: 1996 and 2006 Deprivation Gap in One-Year Relative Survival (%) by Sex in 1996 and 2006 Cancer Type Sex 1996 2006 Survival in most affluent Deprivation gap (%) Oesophagus (C15) Male 30 -4.8 43.9 -8.4 Female 25.3 -0.9 38.2 -7.4 Stomach (C16) 34.9 -5 43.3 -4.4 33.6 40.4 -3.7 Colon (C18) 72.1 -8 76.6 -7.7 69.2 -7.2 75.4 -10.6 Rectum (C19-21) 79 -8.9 82.6 -6.8 77.7 -8.7 82.2 -9.4 Pancreas (C25) 14.9 -2.5 19.4 -4.9 14.2 -3.9 17.5 -2.6 Larynx (C32) 89.2 -6.6 90 Lung (C33, C34) 24.8 -3.3 27.4 -1.6 24.7 -1.5 30.9 -3.1 Malignant melanoma (C43) 95.6 -3.5 97.1 -2.9 97.8 -1.4 98 -0.4 Breast (C50) 95.8 -4 Cervix (C53) 88.9 90.3 -6 Uterus (C54, C55) -4.1 92.8 -3.8 Ovary (C56, C57.0 - C57.7) 67.9 -4.6 71.9 -3.4 Prostate (C61) 89.6 -3.6 97 Testis (C62) 98.9 99.5 -1.7 Kidney (C64-66, C68) 68 -6.9 71.8 -7 63.8 70.9 -4.2 Bladder (C67) 86.1 80.2 -7.1 77.1 -9.9 71.6 -14.2 Brain (C71) 30.2 0.6 36.4 31.6 -7.6 30.6 -1 Hodgkin lymphoma (C81) -1.3 86.5 7.4 94.7 -6.1 86.4 2 Non-Hodgkin lymphoma (C82-85) 73.2 -7.8 77.6 -5.7 75 -10.7 -4.3 Multiple myeloma (C90) 67.1 71.5 -9 64 68.5 0.4 All leukaemia (C91-95) 66.9 65.2 63.1 -5.1 61.1 -1.2 Deprivation gap is the absolute difference (%) between relative survival in the most deprived and the most affluent groups; derived from variance-weighted regression. A negative value means that survival is lower in men and women living in the most deprived areas compared with the most affluent. Rectum includes anus (C19-C21). Ovary excludes overlapping lesion of female genital organs and unspecified female genital organs (C56,C57.0-C57.7). Brain includes malignant brain tumours only (C71). Source: cruk.org/cancerstats You are welcome to reuse this Cancer Research UK statistics content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested style: Cancer Research UK, full URL of the page, Accessed [month] [year].